$159.5 million of cash, cash equivalents and marketable securities as of March 31, 2025
HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
Seeking Alpha / 9 hours ago 1 Views
Seeking Alpha / 9 hours ago 1 Views
$159.5 million of cash, cash equivalents and marketable securities as of March 31, 2025
Comments